| Study | Reason for exclusion |
|---|---|
| Bernard 1989 | RCT of N‐acetylcysteine in 19 patients with ARDS; clinical outcomes not reported |
| Bernard 1991 | RCT of ibuprofen in 30 patients with sepsis; not reported to have ALI/ARDS at randomization |
| Bernard 1997b | RCT of ibuprofen in 455 patients with sepsis; not all patients had ALI/ARDS at randomization |
| Bigatello 1994 | Subgroup analysis of patients with ARDS from RCT of HA‐1A (human monoclonal antiendotoxin antibody) for patients with sepsis |
| Bone 1987 | RCT of methylprednisolone in patients at risk for ARDS; not reported to have ALI at randomization |
| Bone 1995 | RCT of monoclonal antibody to endotoxin (E5) in patients with sepsis; not all patients had ALI/ARDS at randomization |
| Bursten 1996 | RCT of lisofylline in patients at risk for ARDS; not reported to have ALI at randomization |
| Fisher 1994 | RCT of human interleukin 1 receptor antagonist for patients with sepsis; not all patients had ALI/ARDS at randomization |
| Fourrier 1993 | RCT of antithrombin III concentrates in 35 patients with septic shock; not reported to have ALI/ARDS at randomization |
| Heard 1999 | RCT of prostaglandin E1 in 28 patients with ARDS; clinical outcomes not reported |
| Kawai 1988 | Case series of ulinastatin and steroids for patients with sepsis‐induced ARDS |
| Kawai 1990 | Case series of ulinastatin and steroids for patients with sepsis‐induced ARDS |
| Konrad 1995 | RCT of N‐acetylcysteine in intubated surgical intensive care unit patients; not reported to have ALI/ARDS at randomization |
| Looareesuwan 1998 | RCT of pentoxyfylline in 45 patients with severe malaria; not reported to have ALI/ARDS at randomization |
| Lucas 1981 | Quasi‐randomized (allocation based on unit number) trial of steroids during trauma resuscitation; not reported to have ALI/ARDS at randomization |
| Luce 1988 | RCT of methylprednisolone in patients with septic shock at high risk of ARDS; not reported to have ALI at randomization |
| Marshall 2001 | Subgroup analysis of patients with ARDS from RCT of afelimomab (anti‐tumour necrosis factor antibody) for severe sepsis |
| McMichan 1976 | RCT of aprotinin in patients lower extremity or pelvic trauma and shock; did not have ALI/ARDS at randomization |
| McMichan 1982 | RCT of aprotinin in patients lower extremity or pelvic trauma and shock; did not have ALI/ARDS at randomization; same patients enrolled in McMichan 1976 |
| Nelson 1998 | RCT of filgrastim in hospitalized patients with pneumonia; ARDS was exclusion criterion and not reported to have ALI |
| Nelson 2000 | RCT of filgrastim in hospitalized patients with multilobar pneumonia; ARDS was exclusion criterion and not reported to have ALI |
| Ogawa 1996 | RCT of ONO‐5046 Na (a neutrophil elastase inhibitor) in systemic inflammatory response syndrome induced lung injury; trial did not include a placebo or no therapy control group |
| Paran 1995 | RCT of octreotide for pancreatitis; not reported to have ALI/ARDS at randomization |
| Paran 2000 | RCT of octreotide for pancreatitis; not reported to have ALI/ARDS at randomization |
| Radermacher 1988 | Non‐randomized comparison of ketanserin and sodium nitroprusside in patients with ARDS |
| Radermacher 1989 | Non‐randomized crossover comparison of nitroglycerin and prostaglandin E1 in patients with ARDS |
| Root 2003 | RCT of filgrastim for patients with pneumonia and severe sepsis; not all patients had ALI/ARDS at randomization |
| Russell 1990 | Non‐randomized comparison of prostaglandin E1 to control in patients with ARDS |
| Satoh 1998 | RCT of surfactant in patients with unilateral lung injury after thoracic aneurysm surgery |
| Schuster 2003 | RCT of platelet‐activating factor acetylhydrolase in patients with severe sepsis; excluded patients with ARDS and not reported to have ALI at randomization |
| Slotman 1988 | RCT of ketoconazole to prevent ARDS; excluded patients with ARDS and not reported to have ALI at randomization |
| Sprung 1984 | RCT of corticosteroids in patients with septic shock; not reported to have ALI/ARDS at randomization |
| Tanaka 2001 | RCT of lenograstim for patients with sepsis; majority but not all patients had mild‐moderate ALI at randomization |
| Tuxen 1986 | RCT of aprotinin to prevent ARDS in patients with trauma, sepsis, haemorrhage or surgery; excluded patients with ARDS and not reported to have ALI at randomization |
| Umberger 2002 | Cost‐effectiveness data from RCT of methylprednisolone for late phase ARDS (Meduri 1998); no new clinical outcomes reported |
| van der Merwe 1985 | Non‐randomized comparison methylprednisolone to control in patients with severe trauma; not reported to have ALI/ARDS at randomization |
| Vincent 1985 | RCT of dipyridamole for the prevention of ARDS; did not have ALI at randomization |
| Wunderink 2001 | RCT of filgrastim for patients with pneumonia and sepsis; not all patients had ALI/ARDS at randomization |
| Yu 1993 | RCT of ketoconazole to prevent ARDS in patients with sepsis; not reported to have ALI at randomization |
Abbreviations: ALI = acute lung injury, ARDS = acute respiratory distress syndrome, RCT = randomized controlled trial